Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach

Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach Glycoprotein IIb/IIIa inhibitors (GPI) are an adjuvant therapy for the treatment of patients with acute coronary syndromes before, during and after percutaneous coronary intervention (PCI).1 The main adverse reactions are bleeding and thrombocytopenia in 1 –2% of cases, the latter being a rare presentation but with potential catastrophic consequences. Although the pathogenesis of this phenome...
Source: Radcliffe Cardiology - Category: Cardiology Authors: Source Type: research